WO2002060868A3 - Inhibiteurs de la prenyl-proteine transferase - Google Patents

Inhibiteurs de la prenyl-proteine transferase Download PDF

Info

Publication number
WO2002060868A3
WO2002060868A3 PCT/US2001/050527 US0150527W WO02060868A3 WO 2002060868 A3 WO2002060868 A3 WO 2002060868A3 US 0150527 W US0150527 W US 0150527W WO 02060868 A3 WO02060868 A3 WO 02060868A3
Authority
WO
WIPO (PCT)
Prior art keywords
prenyl
protein transferase
inhibitors
protein
prenylation
Prior art date
Application number
PCT/US2001/050527
Other languages
English (en)
Other versions
WO2002060868A2 (fr
Inventor
Ian M Bell
Original Assignee
Merck & Co Inc
Ian M Bell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Ian M Bell filed Critical Merck & Co Inc
Priority to EP01998114A priority Critical patent/EP1332134A2/fr
Priority to CA002426684A priority patent/CA2426684A1/fr
Publication of WO2002060868A2 publication Critical patent/WO2002060868A2/fr
Publication of WO2002060868A3 publication Critical patent/WO2002060868A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés spirocycliques qui inhibent la prényl-protéine transférase et la prénylation de la protéine oncogène Ras. L'invention concerne également des compositions chimiothérapeutiques contenant ces composés, ainsi que des procédés pour inhiber la prényl-protéine transférase et la prénylation de la protéine oncogène Ras.
PCT/US2001/050527 2000-10-25 2001-10-19 Inhibiteurs de la prenyl-proteine transferase WO2002060868A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01998114A EP1332134A2 (fr) 2000-10-25 2001-10-19 Inhibiteurs de la prenyl-proteine transferase
CA002426684A CA2426684A1 (fr) 2000-10-25 2001-10-19 Inhibiteurs de la prenyl-proteine transferase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24323600P 2000-10-25 2000-10-25
US60/243,236 2000-10-25

Publications (2)

Publication Number Publication Date
WO2002060868A2 WO2002060868A2 (fr) 2002-08-08
WO2002060868A3 true WO2002060868A3 (fr) 2003-01-03

Family

ID=22917880

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/050527 WO2002060868A2 (fr) 2000-10-25 2001-10-19 Inhibiteurs de la prenyl-proteine transferase

Country Status (3)

Country Link
EP (1) EP1332134A2 (fr)
CA (1) CA2426684A1 (fr)
WO (1) WO2002060868A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2900652C (fr) 2013-02-15 2021-05-04 Kala Pharmaceuticals, Inc. Composes therapeutiques et utilisations de ceux-ci
BR112015020139A2 (pt) 2013-02-20 2017-07-18 Kala Pharmaceuticals Inc compostos terapêuticos e usos dos mesmos
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
NZ719185A (en) 2013-11-01 2017-11-24 Kala Pharmaceuticals Inc Crystalline forms of therapeutic compounds and uses thereof
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
US10253036B2 (en) 2016-09-08 2019-04-09 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CA3036340A1 (fr) 2016-09-08 2018-03-15 Kala Pharmaceuticals, Inc. Formes cristallines de composes therapeutiques et leurs utilisations
WO2018048746A1 (fr) 2016-09-08 2018-03-15 Kala Pharmaceuticals, Inc. Formes cristallines de composés thérapeutiques et leurs utilisations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358985B1 (en) * 1998-07-02 2002-03-19 Merck & Co., Inc. Inhibitors of prenyl-protein transferase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358985B1 (en) * 1998-07-02 2002-03-19 Merck & Co., Inc. Inhibitors of prenyl-protein transferase

Also Published As

Publication number Publication date
WO2002060868A2 (fr) 2002-08-08
CA2426684A1 (fr) 2002-08-08
EP1332134A2 (fr) 2003-08-06

Similar Documents

Publication Publication Date Title
WO1997038665A3 (fr) Inhibiteurs de la farnesyl-proteine transferase
MX9707459A (es) Inhibidores de farnesil-proteina transferasa, composiciones que los contienen y uso de las composiciones.
AU5455394A (en) Inhibitors of farnesyl-protein transferase
WO2000034437A3 (fr) Inhibiteurs de prenyl-proteine transferase
PL308554A1 (en) Inhibitors of farnesil-protein transferase
WO2004096131A3 (fr) Inhibiteurs de l'activite akt
WO2004096135A3 (fr) Inhibiteurs de l'activite de l'akt
WO2003086279A3 (fr) Inhibiteurs de l'activite de akt
IL173348A0 (en) Thienopyridine and furopyridine kinase inhibitors
MX9705273A (es) Inhibidores de prenil transferasas.
AU2001243158A1 (en) Inhibitors of prenyl-protein transferase
AU2002220559A1 (en) Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
EP1087770A4 (fr) Inhibiteurs de prenyl-proteine transferase
EP1324985A4 (fr) Inhibiteurs de la prenyl-proteine transferase
WO2004014300A3 (fr) Inhibiteurs de la tyrosine kinase
EP1091736A4 (fr) Inhibiteurs de prenyl-proteine transferase
MXPA05013076A (es) Compuestos de isoindolina-1-ona como inhibidores de cinasa.
AU2001238217A1 (en) Inhibitors of prenyl-protein transferase
NZ514576A (en) Substituted 3-cyano-[1.7], [1.5], and [1.8]- naphthyridine inhibitors of tyrosine kinases
AU2001247197A1 (en) Inhibitors of prenyl-protein transferase
WO2002060868A3 (fr) Inhibiteurs de la prenyl-proteine transferase
AU2001227757A1 (en) Inhibitors of prenyl-protein transferase
AU2001238424A1 (en) Inhibitors of prenyl-protein transferase
WO2002079147A3 (fr) Inhibiteurs de la prenyl-proteine-transferase
WO2000034239A3 (fr) Inhibiteurs de prenyl-proteine transferase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001998114

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2426684

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002561019

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002249870

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 2001998114

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001998114

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP